{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:21:45Z","timestamp":1773922905446,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["IJOO"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.4103\/0019-5413.185612","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T09:10:58Z","timestamp":1467796258000},"page":"434-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Caveats of bisphosphonate abuse"],"prefix":"10.1007","volume":"50","author":[{"given":"Sanjay","family":"Agarwala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas M.","family":"Agashe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Mohrir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Moonot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"5004434_CR1","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1007\/s11999-010-1535-x","volume":"468","author":"JD Isaacs","year":"2010","unstructured":"Isaacs JD, Shidiakl L, Harris IA, Szomor ZL. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy. Clin Orthop Relat Res 2010;468:3384\u201392.","journal-title":"Clin Orthop Relat Res"},{"key":"5004434_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1302\/0301-620X.91B8.21518","volume":"91","author":"S Agarwalal","year":"2009","unstructured":"Agarwalal S, Shahl S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: Followup to eight years. J Bone Joint Surg Br 2009;91:1013\u20138.","journal-title":"J Bone Joint Surg Br"},{"key":"5004434_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/rheumatology\/41.3.346-a","volume":"41","author":"S Agarwalal","year":"2002","unstructured":"Agarwalal S, Sulel A, Pai BU, Joshi VR. Alendronate in the treatment of avascular necrosis of the hip. Rheumatology (Oxford) 2002;41:346\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"5004434_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maaloufl N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: A potential complication of alendronate therapy. J Clin Endocrinol Metab 2005;90:1294\u2013301.","journal-title":"J Clin Endocrinol Metab"},{"key":"5004434_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","volume":"28","author":"T Mashibal","year":"2001","unstructured":"Mashibal T, Turner CH, Hiranol T, Forwood MR, Johnston CC, Burr DB. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 2001;28:524\u201331.","journal-title":"Bone"},{"key":"5004434_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S8756-3282(00)00284-2","volume":"27","author":"T Hiranol","year":"2000","unstructured":"Hiranol T, Turner CH, Forwood MR, Johnston CC, Burr DB. Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation? Bone 2000;27:13\u201320.","journal-title":"Bone"},{"key":"5004434_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashibal","year":"2000","unstructured":"Mashibal T, Hiranol T, Turner CH, Forwood MR, Johnston CC, Burr DB. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 2000;15:613\u201320.","journal-title":"J Bone Miner Res"},{"key":"5004434_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4615-0651-5_13","volume":"496","author":"G Boivinl","year":"2001","unstructured":"Boivinl G, Meunie PJ. Changes in bone remodeling rate influence the degree of mineralization of bone which is a determinant of bone strength: Therapeutic implications. Adv Exp Med Biol 2001;496:123\u20137.","journal-title":"Adv Exp Med Biol"},{"key":"5004434_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1359\/jbmr.2003.18.6.1012","volume":"18","author":"O Akkusl","year":"2003","unstructured":"Akkusl O, Polyakova-Akkusl A, Adarl F, Schaffler MB. Aging of microstructural compartments in human compact bone. J Bone Miner Res 2003;18:1012\u20139.","journal-title":"J Bone Miner Res"},{"key":"5004434_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S8756-3282(02)00975-4","volume":"32","author":"TE Ciarelli","year":"2003","unstructured":"Ciarelli TE, Fyhrie DP, Parfitt AM. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 2003;32:311\u20135.","journal-title":"Bone"},{"key":"5004434_CR11","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s11999-010-1583-2","volume":"468","author":"YC Ha","year":"2010","unstructured":"Ha YC, Cho MR, Park KH, Kim SY, Koo KH. Is surgery necessary for femoral insufficiency fractures after long term bisphosphonate therapy? Clin Orthop Relat Res 2010;468:3393\u20138.","journal-title":"Clin Orthop Relat Res"},{"key":"5004434_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","volume":"89","author":"SK Goh","year":"2007","unstructured":"Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: A caution. J Bone Joint Surg Br 2007;89:349\u201353.","journal-title":"J Bone Joint Surg Br"},{"key":"5004434_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s007760200126","volume":"7","author":"J Iwamotol","year":"2002","unstructured":"Iwamotol J, Takedal T. Insufficiency fracture of the femoral neck during osteoporosis treatment: A case report. J Orthop Sci 2002;7:707\u201312.","journal-title":"J Orthop Sci"},{"key":"5004434_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","volume":"39","author":"EB Kwek","year":"2008","unstructured":"Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: A long term complication of alendronate therapy? Injury 2008;39:224\u201331.","journal-title":"Injury"},{"key":"5004434_CR15","first-page":"77","volume":"52","author":"JS Koh","year":"2011","unstructured":"Koh JS, Goh SK, Png MA, Ng AC, Howe TS. Distribution of atypical fractures and cortical stress lesions in the femur: Implications on pathophysiology. Singapore Med J 2011;52:77\u201380.","journal-title":"Singapore Med J"},{"key":"5004434_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shanel","year":"2014","unstructured":"Shanel E, Burrl D, Abrahamsenl B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2014;29:1\u201323.","journal-title":"J Bone Miner Res"},{"key":"5004434_CR17","first-page":"1535","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348:1535\u201341.","journal-title":"Fracture Intervention Trial Research Group. Lancet"},{"key":"5004434_CR18","first-page":"2703","volume":"4","author":"R Bizel","year":"2008","unstructured":"Bizel R, Lamyl O, Peytremann-Bridevauxl I. Osteoporotic fracture in menopausal women: Alendronate reduces the risk. Rev Med Suisse 2008;4:2703.","journal-title":"Rev Med Suisse"},{"key":"5004434_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bone.2005.05.004","volume":"37","author":"D Felsenbergl","year":"2005","unstructured":"Felsenbergl D, Millerl P, Armbrechtl G, Wilsonl K, Schimmer RC, Papapoulos SE. Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis. Bone 2005;37:651\u20134.","journal-title":"Bone"},{"key":"5004434_CR20","unstructured":"Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis; 2014. Available from: http:\/\/www.noforg\/files\/nof\/public\/content\/ file\/2791\/upload\/919pdf. [Last accessed on 2016 Feb 12]."},{"key":"5004434_CR21","unstructured":"Available from: http:\/\/www.who.int\/substance_abuse\/terminology\/abuse\/en\/. [Last accessed on 2014 Jul 27]."},{"key":"5004434_CR22","unstructured":"Available from: http:\/\/www.nice.org.uk\/guidance\/ta161\/ resources\/guidance-alendronate-etidronate-risedronate-raloxifene-strontium-ranelate-and-teriparatide-for-thesecondary-prevention-of-osteoporotic-fragility-fractures-in-postmenopausal-women-amended-pdf. [Last accessed on 2014 Jul 23]."},{"key":"5004434_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3949\/ccjm.78a.11022","volume":"78","author":"SM Ott","year":"2011","unstructured":"Ott SM. What is the optimal duration of bisphosphonate therapy? Cleve Clin J Med 2011;78:619\u201330.","journal-title":"Cleve Clin J Med"},{"key":"5004434_CR24","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1503\/cmaj.121698","volume":"185","author":"S Chatterjeel","year":"2013","unstructured":"Chatterjeel S. Atypical femoral fractures associated with long term bisphosphonate use. CMAJ 2013;185:1248.","journal-title":"CMAJ"},{"key":"5004434_CR25","first-page":"567","volume":"76","author":"S Agarwal","year":"2010","unstructured":"Agarwal S, Agarwal S, Guptal P, Agarwal PK, Agarwal G, Bansall A. Risk of atypical femoral fracture with long term use of alendronate (bisphosphonates): A systemic review of literature. Acta Orthop Belg 2010;76:567\u201371.","journal-title":"Acta Orthop Belg"},{"key":"5004434_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/230949901101900121","volume":"19","author":"K Wangl","year":"2011","unstructured":"Wangl K, Moavenil A, Dowrickl A, Liewl S. Alendronate-associated femoral insufficiency fractures and femoral stress reactions. J Orthop Surg (Hong Kong) 2011;19:89\u201392.","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"5004434_CR27","first-page":"46","volume":"140","author":"SK Bhadada","year":"2014","unstructured":"Bhadada SK, Sridharl S, Muthukrishnanl J, Mithal A, Sharma DC, Bhansalil A, et al. Predictors of atypical femoral fractures during long term bisphosphonate therapy: A case series & review of literature. Indian J Med Res 2014;140:46\u201354.","journal-title":"Indian J Med Res"},{"key":"5004434_CR28","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.2106\/JBJS.L.00775","volume":"95","author":"A Unnanuntanal","year":"2013","unstructured":"Unnanuntanal A, Salehl A, Mensah KA, Kleimeyer JP, Lane JM. Atypical femoral fractures: What do we know about them? AAOS exhibit selection. J Bone Joint Surg Am 2013;95:e81\u201313.","journal-title":"J Bone Joint Surg Am"},{"key":"5004434_CR29","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1007\/s11999-011-1828-8","volume":"469","author":"MB Banffy","year":"2011","unstructured":"Banffy MB, Vrahas MS, Ready JE, Abraham JA. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures. Clin Orthop Relat Res 2011;469:2028\u201334.","journal-title":"Clin Orthop Relat Res"},{"key":"5004434_CR30","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2214\/AJR.09.3588","volume":"194","author":"SS Chan","year":"2010","unstructured":"Chan SS, Rosenberg ZS, Chanl K, Capecil C. Subtrochanteric femoral fractures in patients receiving long term alendronate therapy: Imaging features. AJR Am J Roentgenol 2010;194:1581\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"5004434_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/BOT.0b013e31827240ae","volume":"27","author":"KA Egol","year":"2013","unstructured":"Egol KA, Park JH, Prenskyl C, Rosenberg ZS, Peckl V, Tejwani NC. Surgical treatment improves clinical and functional outcomes for patients who sustain incomplete bisphosphonate-related femur fractures. J Orthop Trauma 2013;27:331\u20135.","journal-title":"J Orthop Trauma"}],"container-title":["Indian Journal of Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.4103\/0019-5413.185612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.4103\/0019-5413.185612\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.4103\/0019-5413.185612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T19:52:01Z","timestamp":1644522721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.4103\/0019-5413.185612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["5004434"],"URL":"https:\/\/doi.org\/10.4103\/0019-5413.185612","relation":{},"ISSN":["0019-5413","1998-3727"],"issn-type":[{"value":"0019-5413","type":"print"},{"value":"1998-3727","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"1 August 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}